Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $76.89, a high estimate of ...

The analysis of recent analyst actions sheds light on the perception of Lovesac by financial experts. The following summary ...

SI-BONE, Inc. reported $48 million in sales and an operating loss of $4.5 million for the quarter ending December 31, 2024.

In a report released on April 8, James Bullen from Canaccord Genuity maintained a Buy rating on Deep Yellow Limited (DYLLF – Research Report), ...

In a report released on April 8, Reg Spencer from Canaccord Genuity maintained a Buy rating on Iperionx Limited (IPX – Research Report), with a ...

Fintel reports that on April 10, 2025, Canaccord Genuity initiated coverage of BlackSky Technology (NYSE:BKSY) with a Buy ...

As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...

BCE (TSE:BCE – Free Report) (NYSE:BCE) had its target price decreased by Canaccord Genuity Group from C$33.50 to C$31.50 in a ...

Canaccord Genuity Group set a C$12.50 target price on Cipher Pharmaceuticals (TSE:CPH – Free Report) (NASDAQ:CPHR) in a research note released on Monday morning,BayStreet.CA reports. The brokerage ...

Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic ...

China’s restrictions on exports of medium and heavy rare earths will disrupt global supply chains, opening the door for ...